Biosergen attacks invisible threat of fungal infections
How big is the threat of fungal infections and the strains that develop drug resistance? Swedish biotech company Biosergen develops antimyotic drugs that they...
Alligator’s CEO comments on restructuring plan
Alligator Bioscience is coming off a high after reaching the primary endpoint in the OPTIMIZE-1 phase II trial with lead candidate mitazalimab. However, together...
BiBB’s founder on the first US clinical cases with EndoDrill
BiBBInstruments is a medical device company, based in Lund, developing EndoDrill – an electric-driven endoscopic ultrasound device for tissue sampling. The company recently announced...
Cereno’s CEO on being granted “Compassionate Use”
Cereno Scientific has been granted Expanded Access, also known as "compassionate use," by the FDA for drug candidate CS1 in rare disease pulmonary arterial...
Saniona raises capital to advance epilepsy programme
Saniona’s CEO Thomas Feldthus visited BioStock's studio for an interview discussing the company's drug development pipeline with epilepsy candidate SAN711 leading the way. We...
Alligator meets primary endpoint with CD40 agonist in pancreatic cancer
Alligator Bioscience has released positive top-line data from the phase II trial assessing the efficacy of the CD40 agonist mitazalimab in pancreatic cancer. Having...
BioStock Investor Pitch: Saniona
Danish biopharma company Saniona has a broad drug development pipeline based on ion channel modulators. The company's focus is on epilepsy, and candidate SAN711...
BioStock Investor Pitch: Oncoinvent
Oncoinvent's CEO Anders Månsson visited BioStock's studio to talk about the development of the radiopharmaceutical Radspherin for peritoneal carcinomatosis. In his presentation, he delves...
Can AI help solve cancer? – Evaxion Biotech talks AI, cancer...
At the end of August, Evaxion Biotech announced a change in top management, hiring Christian Kanstrup as CEO. Kanstrup stopped by the BioStock Studio...
NLSDays 2023: Positive vibes across Nordic life science partnering landscape
BioStock attended NLSDays 2023, the 10th anniversary edition of the Nordic Life Science partnering conference. On November 29 and 30, we got a chance...